SHIONOGI & CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,144 JPY | +0.21% |
|
-6.36% | +5.09% |
| May. 14 | Japan's Nikkei drifts sideways as more earnings, US CPI awaited | RE |
| May. 13 | Japan's Shionogi says COVID treatment did not meet endpoint in late-stage trial | RE |
ETFs positioned on Shionogi & Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.69% | 19 M€ | +11.55% | ||
| 2.51% | 7 M€ | +9.05% | - | |
| 1.07% | 57 M€ | +18.61% | ||
| 1.05% | 10 M€ | +16.91% | - | |
| 1.04% | 240 M€ | +17.87% | ||
| 0.92% | 64,792 M€ | +17.80% | ||
| 0.86% | 14 M€ | +18.31% | ||
| 0.85% | 28,258 M€ | +17.79% | - | |
| 0.84% | 51 M€ | -.--% | - | |
| 0.84% | 174 M€ | -.--% | - | |
| 0.72% | 15,324 M€ | +16.83% | - | |
| 0.61% | 2 M€ | +9.19% | - | |
| 0.61% | 2 M€ | -.--% | - | |
| 0.59% | 70 M€ | +18.25% | ||
| 0.54% | 79 M€ | +18.46% | ||
| 0.42% | 0 M€ | 0.00% | - | |
| 0.40% | 14 M€ | +18.57% | ||
| 0.38% | 17 M€ | +11.76% | - | |
| 0.36% | 9,760 M€ | +18.42% | ||
| 0.36% | 4,929 M€ | +18.70% | ||
| 0.34% | 25 M€ | +18.33% | ||
| 0.26% | 63,295 M€ | +18.38% | - | |
| 0.26% | 140,441 M€ | +18.33% | ||
| 0.26% | 20,360 M€ | +17.15% | - | |
| 0.10% | 4 M€ | -.--% | - | |
| 0.08% | 7 M€ | +6.58% | - | |
| 0.07% | 10 M€ | -3.35% | - | |
| 0.06% | 7 M€ | +0.11% | - | |
| 0.06% | 264 M€ | -.--% | - | |
| 0.05% | 187 M€ | +10.81% | - |
Shionogi & Co., Ltd. specializes in development, manufacturing and marketing of pharmaceutical products. The group's activity is organized around 3 families of products:
- prescription products: drugs for the treatment of cardiovascular and infectious diseases, diabetes, allergic reactions, etc.;
- OTC products: analgesic products, vitamins and tonics, etc.;
- diagnosis products: primarily for detection and treatment of cardiovascular diseases and immune system.
Sector
Pharmaceuticals
Calendar
2024-06-06
- R&D Day
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
7,129
JPY
Average target price
7,805
JPY
Spread / Average Target
+9.49%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +5.09% | 13B | |
| +32.09% | 693B | |
| +29.39% | 584B | |
| -1.34% | 372B | |
| +20.34% | 332B | |
| +7.39% | 294B | |
| +13.78% | 239B | |
| -3.03% | 211B | |
| +10.02% | 210B | |
| +8.49% | 168B |
- Stock Market
- Equities
- 4507 Stock
- Funds and ETFs Shionogi & Co., Ltd.
